Up to 30 percent of HIV patients who are appropriately treated with antiretroviral therapies develop emphysema. New research from Weill Cornell Medicine investigators has uncovered a mechanism that might explain why this lung damage occurs.
The Bench to Bedside Initiative program, part of Weill Cornell Medicine's entrepreneurship lab, helps medical and doctoral students, clinicians and researchers launch technologies into startups.
Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center researchers have developed a preclinical model of colorectal cancer in which the disease forms in the correct anatomical location.
Dr. Arjun Srinivasan of the CDC delivered the keynote lecture at the symposium, "Antimicrobial Resistance: Research Synergies in Human and Animal Medicine," on Cornell's Ithaca campus May 4.
A study identified the sugar alcohol erythritol, which can be metabolized by, and even produced in, the human body as a biomarker for increasing fat mass.
Kathleen M. Rasmussen, professor of nutritional sciences, has been recognized by the American Society for Nutrition with the Conrad A. Elvehjem Award for Public Service in Nutrition.
Dig into digital agriculture, comprehend plant breeding biotechnology, and learn out how the microbiome may solve food production problems at an agricultural technology and partnership forum June 7.
Food entrepreneurs took part in the panel discussion Advancing Food Entrepreneurship April 28 at the Statler Hotel, part of the Entrepreneurship at Cornell Celebration conference.
Biotia, a startup offering microbial surveillance for hospitals, is a joint venture between researchers at Weill Cornell Medicine and Cornell Tech, founded through the Runway Startup program at the Jacobs Technion-Cornell Institute at Cornell Tech.
